Maze Therapeutics' Senior Vice President of Finance sold shares towards the end of January 2026, all while the company's stock had one of the best first-year performances of a biopharmaceutical ...

After Maze Therapeutics opted not to participate in the National Advertising Division’s (NAD’s) self-regulatory process for monitoring promotional claims, a case brought by competitor Vertex ...

Fierce 15 winner Maze Therapeutics just added $190 million to its fundraising pile in time to help its lead candidate, MZE001, make a clinical debut. Maze wrapped up the fundraising round on Monday.

Sanofi is offering up to $750 million in upfront cash and biobucks for Maze Therapeutics’ glycogen synthase 1 (GYS1) program, including a lead asset that’s recently completed a phase 1 trial for ...

"I think the secret of maize maze appeal lies in their scale - it is very difficult to find places where you can get hopelessly lost and completely lose your bearings." Great Western Maze opens July, ...

There are two kinds of people in this world: the kind who love mazes, and the kind who hate mazes. I don’t know about you, but it’s hard to imagine a more stressful situation than being trapped in a ...